Literature DB >> 30008053

Recombinant helical plant virus-based nanoparticles for vaccination and immunotherapy.

Kannan Badri Narayanan1,2, Sung Soo Han3,4.   

Abstract

Plant virus-based nanoparticles (PVNs) are self-assembled capsid proteins of plant viruses, and can be virus-like nanoparticles (VLPs) or virus nanoparticles (VNPs). Plant viruses showing helical capsid symmetry are used as a versatile platform for the presentation of multiple copies of well-arrayed immunogenic antigens of various disease pathogens. Helical PVNs are non-infectious, biocompatible, and naturally immunogenic, and thus, they are suitable antigen carriers for vaccine production and can trigger humoral and/or cellular immune responses. Furthermore, recombinant PVNs as vaccines and adjuvants can be expressed in prokaryotic and eukaryotic systems, and plant expression systems can be used to produce cost-effective antigenic peptides on the surfaces of recombinant helical PVNs. This review discusses various recombinant helical PVNs based on different plant viral capsid shells that have been developed as prophylactic and/or therapeutic vaccines against bacterial, viral, and protozoal diseases, and cancer.

Entities:  

Keywords:  Antigens; Coat protein; Helical plant virus; Immunotherapy; Nanoparticle; Vaccine

Mesh:

Substances:

Year:  2018        PMID: 30008053     DOI: 10.1007/s11262-018-1583-y

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  96 in total

1.  Engineering zucchini yellow mosaic potyvirus as a non-pathogenic vector for expression of heterologous proteins in cucurbits.

Authors:  T Arazi; S G Slutsky; Y M Shiboleth; Y Wang; M Rubinstein; S Barak; J Yang; A Gal-On
Journal:  J Biotechnol       Date:  2001-04-27       Impact factor: 3.307

2.  Architecture of the potyviruses.

Authors:  Michele McDonald; Amy Kendall; Wen Bian; Ian McCullough; Elizabeth Lio; Wendy M Havens; Said A Ghabrial; Gerald Stubbs
Journal:  Virology       Date:  2010-07-03       Impact factor: 3.616

Review 3.  Porcine Reproductive and Respiratory Syndrome Virus (PRRSV): Pathogenesis and Interaction with the Immune System.

Authors:  Joan K Lunney; Ying Fang; Andrea Ladinig; Nanhua Chen; Yanhua Li; Bob Rowland; Gourapura J Renukaradhya
Journal:  Annu Rev Anim Biosci       Date:  2015-11-20       Impact factor: 8.923

4.  Rapid production of specific vaccines for lymphoma by expression of the tumor-derived single-chain Fv epitopes in tobacco plants.

Authors:  A A McCormick; M H Kumagai; K Hanley; T H Turpen; I Hakim; L K Grill; D Tusé; S Levy; R Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

5.  The genome-linked protein and 5' end RNA sequence of plum pox potyvirus.

Authors:  J L Riechmann; S Laín; J A García
Journal:  J Gen Virol       Date:  1989-10       Impact factor: 3.891

6.  Immunization with a chimeric tobacco mosaic virus containing an epitope of outer membrane protein F of Pseudomonas aeruginosa provides protection against challenge with P. aeruginosa.

Authors:  J Staczek; M Bendahmane; L B Gilleland; R N Beachy; H E Gilleland
Journal:  Vaccine       Date:  2000-04-28       Impact factor: 3.641

7.  TMV-peptide fusion vaccines induce cell-mediated immune responses and tumor protection in two murine models.

Authors:  Alison A McCormick; Tina A Corbo; Sherri Wykoff-Clary; Long V Nguyen; Mark L Smith; Kenneth E Palmer; Gregory P Pogue
Journal:  Vaccine       Date:  2006-07-05       Impact factor: 3.641

Review 8.  Self-assembling protein nanoparticles in the design of vaccines.

Authors:  Jacinto López-Sagaseta; Enrico Malito; Rino Rappuoli; Matthew J Bottomley
Journal:  Comput Struct Biotechnol J       Date:  2015-11-26       Impact factor: 7.271

9.  High genetic diversity in the coat protein and 3 untranslated regions among geographical isolates of Cardamom mosaic virus from south India.

Authors:  T Jacob; T Jebasingh; M N Venugopal; R Usha
Journal:  J Biosci       Date:  2003-09       Impact factor: 2.795

10.  Development of a Genetically-Engineered, Candidate Polio Vaccine Employing the Self-Assembling Properties of the Tobacco Mosaic Virus Coat Protein.

Authors:  Joel R Haynes; Janet Cunningham; Adolph von Seefried; Michael Lennick; Robert T Garvin; Shi-Hsiang Shen
Journal:  Biotechnology (N Y)       Date:  1986
View more
  1 in total

Review 1.  Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update.

Authors:  Uttpal Anand; Shweta Jakhmola; Omkar Indari; Hem Chandra Jha; Zhe-Sheng Chen; Vijay Tripathi; José M Pérez de la Lastra
Journal:  Front Immunol       Date:  2021-06-30       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.